IndraLab
Statements
reach
"Thus, this positive association between CD44 and PD-L1 might provide the rationale for investigating the effect of monoclonal PD-L1/PD-1 antibodies administration on the CD44 expression and stemness of TNBC cells in affected patients.The current systematic review has several strengths."
sparser
"Consequently, our state-of-the-art 3D models can be utilized to assess the biological activity of novel multi-target molecules designed to interact with CD44 and PD-L1, with the objective of eradicating aggressive CD44 + populations and augmenting the efficacy of immune checkpoint inhibitors."
sparser
"A study found that in TNBC and NSCLC, the cell surface adhesion receptor CD44 was a critical positive regulator of PD-L1; CD44 could bind to the regulatory region of PD-L1, which contains the CD44-ICD binding site and activates PD-L1 transcription through its ICD; the activated PD-L1 could promote tumor cell proliferation independent of T cell response ( xref )."